A domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus affects transcriptional activation and binding to nuclear heterochromatin

被引:44
作者
Viejo-Borbolla, A
Kati, E
Sheldon, JA
Nathan, K
Mattsson, K
Szekely, L
Schulz, TF
机构
[1] Hannover Med Sch, Dept Virol, D-30625 Hannover, Germany
[2] Karolinska Inst, Microbiol & Tumorbiol Ctr, Stockholm, Sweden
关键词
D O I
10.1128/JVI.77.12.7093-7100.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The latency-associated nuclear antigen 1 (LANA-1) of Kaposi's sarcoma-associated herpesvirus (KSHV) is required for the maintenance and replication of viral episomal DNA. The binding sites for nuclear heterochromatin and transcriptional repressor complexes are located in an amino-terminal region of LANA-1, whereas those for viral episomal DNA, p53, pRB, and members of the BRD/fsh family of nuclear proteins are located in its carboxy-terminal domain. LANA-1 activates or represses several cellular and viral promoters. In this report we show that a domain of 15 amino acids (amino acids 1129 to 1143), located close to the carboxy-terminal end of LANA-1, is required for the interaction of LANA-1 with nuclear heterochromatin or nuclear matrix, and for the ability of LANA-1 to activate the Epstein-Barr virus Cp promoter. LANA-1 proteins that are tightly associated with nuclear heterochromatin or matrix differ in molecular weight from LANA-1 proteins that can be dissociated from the nuclear matrix by high-salt buffers, suggesting that posttranslational modifications may determine the association of LANA-1 with nuclear heterochromatin or matrix.
引用
收藏
页码:7093 / 7100
页数:8
相关论文
共 45 条
[1]   The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element [J].
An, JB ;
Lichtenstein, AK ;
Brent, G ;
Rettig, MB .
BLOOD, 2002, 99 (02) :649-654
[2]   Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen [J].
Ballestas, ME ;
Chatis, PA ;
Kaye, KM .
SCIENCE, 1999, 284 (5414) :641-644
[3]   Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA [J].
Ballestas, ME ;
Kaye, KM .
JOURNAL OF VIROLOGY, 2001, 75 (07) :3250-3258
[4]   KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS INFECTS ENDOTHELIAL AND SPINDLE CELLS [J].
BOSHOFF, C ;
SCHULZ, TF ;
KENNEDY, MM ;
GRAHAM, AK ;
FISHER, C ;
THOMAS, A ;
MCGEE, JO ;
WEISS, RA ;
OLEARY, JJ .
NATURE MEDICINE, 1995, 1 (12) :1274-1278
[5]   Kaposi's sarcoma-associated herpesvirus [J].
Boshoff, C ;
Weiss, RA .
ADVANCES IN CANCER RESEARCH, VOL 75, 1998, 75 :57-86
[6]   KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-RELATED BODY-CAVITY-BASED LYMPHOMAS [J].
CESARMAN, E ;
CHANG, Y ;
MOORE, PS ;
SAID, JW ;
KNOWLES, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (18) :1186-1191
[7]   IDENTIFICATION OF HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-ASSOCIATED KAPOSIS-SARCOMA [J].
CHANG, Y ;
CESARMAN, E ;
PESSIN, MS ;
LEE, F ;
CULPEPPER, J ;
KNOWLES, DM ;
MOORE, PS .
SCIENCE, 1994, 266 (5192) :1865-1869
[8]   The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells [J].
Cotter, MA ;
Robertson, ES .
VIROLOGY, 1999, 264 (02) :254-264
[9]   The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus [J].
Cotter, MA ;
Subramanian, C ;
Robertson, ES .
VIROLOGY, 2001, 291 (02) :241-259
[10]  
Denis GV, 2000, CELL GROWTH DIFFER, V11, P417